Catalina Capital Group, LLC Adagene Inc. Transaction History
Catalina Capital Group, LLC
- $266 Billion
- Q2 2024
A detailed history of Catalina Capital Group, LLC transactions in Adagene Inc. stock. As of the latest transaction made, Catalina Capital Group, LLC holds 16,752 shares of ADAG stock, worth $58,464. This represents 0.02% of its overall portfolio holdings.
Number of Shares
16,752Holding current value
$58,464% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding ADAG
# of Institutions
14Shares Held
9.89MCall Options Held
0Put Options Held
0-
Wu Xi App Tec Co., Ltd. Shanghai, F43.98MShares$13.9 Million52.26% of portfolio
-
Fil LTD Hamilton, D03.83MShares$13.4 Million0.01% of portfolio
-
Sc China Holding LTD N/A, K31.34MShares$4.69 Million0.15% of portfolio
-
General Atlantic LLC New York, NY264KShares$921,3600.03% of portfolio
-
Barclays PLC London, X0187KShares$652,2910.0% of portfolio
About Adagene Inc.
- Ticker ADAG
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,423,200
- Market Cap $152M
- Description
- Adagene Inc., a clinical stage biopharmaceutical company, engages in the research, development, and production of monoclonal antibody drugs for cancers. The company's product candidates include ADG106, a human ligand-blocking agonistic anti-CD137 monoclonal antibodies (mAbs) that is in Phase 1b/2 clinical trials for the treatment advanced solid ...